Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

PURPOSE: The origin licensing factors minichromosome maintenance 2 (Mcm2) and Geminin have recently been identified as critical regulators of growth and differentiation. Here we have investigated the regulation of these licensing factors together with Ki67 to further elucidate the cell cycle kineti...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Dudderidge, T, Stoeber, K, Loddo, M, Atkinson, G, Fanshawe, T, Griffiths, D, Williams, G
Formato:	Journal article
Idioma:	English
Publicado em:	2005

Registos relacionados

Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
Por: Kingsbury, SR, et al.
Publicado em: (2005)

Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
Por: Nurhan Güler, et al.
Publicado em: (2012-01-01)

Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
Por: Marzena Podhorska-Okolow, et al.
Publicado em: (2010-11-01)

MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors
Por: Ritika Raja, et al.
Publicado em: (2021-01-01)

MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma
Por: Zohreh Jaafari-Ashkavandi, et al.
Publicado em: (2019-01-01)

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
Por: Arisa Nishimukai, et al.
Publicado em: (2017-01-01)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
Por: I. Pergolini, et al.
Publicado em: (2019-10-01)

Gene experison of cell proliferative marker Ki67 in breast cancer
Por: Golmohammadi R (PhD), et al.
Publicado em: (2011-09-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
Por: Christina Marouda, et al.
Publicado em: (2024-01-01)

Evaluation of Nuclear Morphometry and Ki-67 Proliferative Marker in Astrocytomas: An Ambispective Study
Por: Palak Nanda, et al.
Publicado em: (2023-01-01)

A study on the role of proliferative index marker Ki67 in breast carcinoma
Por: Vijetha Vikram, et al.
Publicado em: (2022-11-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
Por: Nasrin Shayanfar, et al.
Publicado em: (2010-06-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
Por: Nasrin Shayanfar, et al.
Publicado em: (2010-05-01)

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
Por: Huberman Joel, et al.
Publicado em: (2006-08-01)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
Por: Muhammad Zain Mehdi, et al.

Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67
Por: Ramesh Babu Telugu, et al.
Publicado em: (2016-01-01)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
Por: Gasperetti F, et al.
Publicado em: (2011-03-01)

Expression of proliferative marker Ki-67 in epithelial dysplasia and squamous cell carcinoma of oral cavity
Por: Payal Doctor, et al.
Publicado em: (2023-04-01)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
Por: Bachmann Ingeborg M, et al.
Publicado em: (2010-04-01)

Comment on “PCNA and Ki67: Prognostic proliferation markers for oral cancer”
Por: Muthupandian Saravanan
Publicado em: (2024-06-01)

Expression of Ki67 as a Prognostic Marker in Invasive Breast Carcinoma
Por: Rashi Ahuja, et al.
Publicado em: (2017-07-01)

Association of degree of expression of ki 67 proliferative cell marker with aggressive giant cell tumor of the bone
Por: Wan Faisham Nu Man, Wan Ismail
Publicado em: (2013)

Geminin is required for the maintenance of pluripotency.
Por: Golnaz A Tabrizi, et al.
Publicado em: (2013-01-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
Por: Dorsay Sadeghian, et al.
Publicado em: (2022-02-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
Por: Fahimeh Rezazadeh, et al.
Publicado em: (2017-09-01)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
Por: G.S. Starodub, et al.
Publicado em: (2016-04-01)

The expression of Ki-67 marker in the hydatidiform mole
Por: Ecaterina Carpenco, et al.
Publicado em: (2022-12-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
Por: Fatima S. Al-Sarraf, et al.
Publicado em: (2015-07-01)

The importance of prognostic markers of tumor progression Ki-67 and р53 in the breast cancer
Por: Bondareva V.A., et al.
Publicado em: (2007-01-01)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
Por: Yunbao Pan, et al.
Publicado em: (2017-01-01)

Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas Estudo clinicopatológico com avaliação do índice de proliferação celular avaliado pelo Ki-67 em osteossarcomas humanos
Por: Larissa Cardoso Marinho, et al.
Publicado em: (2005-12-01)

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
Por: Dudderidge, T, et al.
Publicado em: (2007)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
Por: Agnieszka Pinkowska, et al.
Publicado em: (2021-12-01)

Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma
Por: Ela Araz Server, et al.
Publicado em: (2019-04-01)

Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
Por: Marković Olivera, et al.
Publicado em: (2005-01-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
Por: T. A. Bogush, et al.
Publicado em: (2023-07-01)

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
Por: Mojca Založnik, et al.
Publicado em: (2024-07-01)

Role of Proliferative Marker (Ki-67) and ER, PR in Cervical Epithelial Lesions with Clinicopathological Association: A Cross-sectional Study
Por: Shrabani Mitra, et al.
Publicado em: (2025-02-01)

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma
Por: Sarocha Vivatvakin, et al.
Publicado em: (2021-07-01)

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma
Por: Betül Bolat Küçükzeybek, et al.
Publicado em: (2013-09-01)